Adv Sci (Weinh)

1. REN T, Qiu J, Chen F, Jiang Q, et al
   Targeting Glutamine Metabolism Transporter SLC25A22 Enhances CD8+ T-Cell Function and Anti-PD-1 Therapy Efficacy in Cervical Squamous Cell Carcinoma: Integrated Metabolomics, Transcriptomics and T-Cell-Incorporated Tumor Organoid Studies.
   Adv Sci (Weinh). 2025;12:e02225.
   

   >> Share

   
   

   
   Am J Reprod Immunol

2. MACINAS DV JR, Tantengco OAG, de Paz-Silava SLM, Kammala AK, et al
   Comparative Analysis of Vaginal Inflammatory Cytokines Among HPV-Positive and HPV-Negative Women in Manila, Philippines.
   Am J Reprod Immunol. 2025;94:e70148.
   

   >> Share

   
   

   
   Ann Med Surg (Lond)

3. OBEAGU EI
   Anemia and hematocrit decline in cervical cancer: unveiling clinical consequences and management strategies.
   Ann Med Surg (Lond). 2025;87:5784-5791.
   

   >> Share

   
   

   
   Appl Immunohistochem Mol Morphol

4. KAWAGUCHI R, Uchiyama T, Sugimoto S, Kamibayashi J, et al
   Tissue Factor Pathway Inhibitor-2 Expression in Uterine Cervical Clear Cell Carcinoma: A Potential Biomarker for Clinical Diagnosis.
   Appl Immunohistochem Mol Morphol. 2025;33:315-320.
   

   >> Share

   
   

   
   Biochim Biophys Acta Mol Basis Dis

5. SHEN J, Zhang D, Zheng Q, Zhang Z, et al
   ClC-3 inhibition induces autophagy to reverse cisplatin resistance in cervical cancer via the Akt/mTOR pathway.
   Biochim Biophys Acta Mol Basis Dis. 2025 Sep 2:168030.
   

   >> Share

   
   

   
   Biochim Biophys Acta Mol Cell Res

6. HSIN MC, Wang PH, Chen PN, Hsieh YH, et al
   S100A16 knockdown reduces RPN2 expression and inhibits beta-catenin/TCF signaling, leading to suppressed metastasis in cervical cancer cells.
   Biochim Biophys Acta Mol Cell Res. 2025;1872:120053.
   

   >> Share

   
   

   
   BMC Cancer

7. YANG Q, Han X
   Prognostic value of risk factors in cervical squamous cell carcinoma based on tumour infiltration depth.
   BMC Cancer. 2025;25:1412.
   

   >> Share

   
   

   
   BMC Med Inform Decis Mak

8. JEMANE KC, Kuyu MB, Tegenaw GS
   Developing multimodal cervical cancer risk assessment and prediction model based on LMIC hospital patient card sheets and histopathological images.
   BMC Med Inform Decis Mak. 2025;25:322.
   

   >> Share

   
   

   
   BMC Public Health

9. EMAGNENEH T, Mulugeta C, Ejigu B, Alamrew A, et al
   Uptake of cervical cancer screening and its associated factors in Africa: an umbrella review of systematic reviews and meta-analyses.
   BMC Public Health. 2025;25:2968.
   

   >> Share

   
   

   
   BMJ Glob Health

10. NISHA M, Bateson D, Saville M, Nightingale CE, et al
    The role of non-medical providers in increasing access to cervical screening: a scoping review.
    BMJ Glob Health. 2025;10:e019041.
    

    >> Share

    
    

    
    BMJ Open

11. ORANRATANAPHAN S, Moonchai K, Pohthipornthawat N, Santibenchakul S, et al
    Knowledge, attitudes and practices regarding cervical cancer screening among women in the Dindaeng community, Bangkok, Thailand: a cross-sectional community-based study.
    BMJ Open. 2025;15:e100896.
    

    >> Share

    
    

    
    Br J Cancer

12. MATHEWS CS, Sargent A, Cuschieri K, Rebolj M, et al
    HPValidate-human papillomavirus testing with DNA and mRNA assays on self-collected samples in cervical screening: comparison of test characteristics on three self-sampling devices.
    Br J Cancer. 2025;133:665-673.
    

    >> Share

    
    

    
    Brachytherapy

13. KUETE LT, Glennon A, Ptashnik S, Schickel M, et al
    Interstitial cervical needle-guide ring-cap prototype for patient-specific ring-and-tandem brachytherapy.
    Brachytherapy. 2025;24:703-710.
    

    >> Share

    
    
14. GULSTENE S, Amjad R, Mendez LC
    Understanding the value of paracervical block during gynecologic brachytherapy: A systematic review of the literature.
    Brachytherapy. 2025;24:694-702.
    

    >> Share

    
    

    
    Braz J Med Biol Res

15. MARI NL, Souza MVF, Meirelles LEF, Carvalho ARBA, et al
    Chrysin induces cell death and inhibits migration and invasion in squamous cervical carcinoma using a three-dimensional cell culture model.
    Braz J Med Biol Res. 2025;58:e14692.
    

    >> Share

    
    

    
    Bull World Health Organ

16. FUADY A, Kasempa C, Lucas E, Nyambe N, et al
    Economic evaluation of thermal ablation compared to cryotherapy and loop diathermy in a screen-and-treat approach to cervical cancer, Zambia.
    Bull World Health Organ. 2025;103:530-540.
    

    >> Share

    
    

    
    Cad Saude Publica

17. MIGOWSKI A
    Past, present, and future of screening for cervical cancer in Brazil: lessons learned?
    Cad Saude Publica. 2025;41:e00134625.
    

    >> Share

    
    

    
    Cancer Causes Control

18. OPITO R, Lacika JL, Wabinga H, Orach CG, et al
    Symptom attributions by cervical cancer patients attending specialized care at the Uganda cancer institute: a cross-sectional study.
    Cancer Causes Control. 2025 Sep 2. doi: 10.1007/s10552-025-02062.
    

    >> Share

    
    

    
    Cancer Control

19. SADANA A, Omoto J, Sorgi K, Rahangdale L, et al
    Feasibility of Intravaginal Artesunate as an Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial.
    Cancer Control. 2025;32:10732748251374418.
    

    >> Share

    
    

    
    Cancer Epidemiol Biomarkers Prev

20. PHILLIPS SA, Denoel S, Wentzensen N, Arbyn M, et al
    Accuracy of HPV Self-Collection Compared with Clinician-Collected HPV Testing and Cytology: A Meta-analysis.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1467-1471.
    

    >> Share

    
    

    
    Cancer Med

21. DE SOUSA C, Eksteen C, Engelbrecht AM
    Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis.
    Cancer Med. 2025;14:e71194.
    

    >> Share

    
    

    
    Cancer Treat Res Commun

22. HUANG D, Baldandorj B, Odkhuu E, Amartuvshin E, et al
    ERO1alpha regulates curcumin-induced autophagy via PI3K/AKT pathway.
    Cancer Treat Res Commun. 2025;44:100957.
    

    >> Share

    
    

    
    Clin Oncol (R Coll Radiol)

23. DANKULCHAI P, Prasartseree T, Sittiwong W, Thephamongkhol K, et al
    Early Results of Hypofractionated Chemoradiation in Cervical Cancer with 44 Gy/ 20 F vs 45 Gy/ 25 F: A Phase II, Open-Label, Randomised Controlled Trial (HYPOCx-iRex Trial).
    Clin Oncol (R Coll Radiol). 2025;46:103907.
    

    >> Share

    
    
24. GAN G
    Response to Letter Regarding 'Feasibility Study of an Efficient Plan Pool Adaptive Radiotherapy Technology Based on Low-Dose Computed Tomography for Cervical Cancer'.
    Clin Oncol (R Coll Radiol). 2025;46:103922.
    

    >> Share

    
    

    
    Comput Biol Med

25. SAINI S, Liu X
    Dendrite cross attention for high-dose-rate brachytherapy distribution planning.
    Comput Biol Med. 2025;196.
    

    >> Share

    
    

    
    Cureus

26. ASWANI A, Butt E, Akinooye O, Chokapirat C, et al
    Navigating Cervical Cancer Risk in a Patient With Classic Congenital Adrenal Hyperplasia (CAH): A Case Report.
    Cureus. 2025;17:e89331.
    

    >> Share

    
    
27. KULAL S, H K J, Shivapura Anandakumar A, H R R, et al
    The Sociocultural Determinants of Cervical Cancer Outcomes in India: A Critical Review of Diagnostic Delays and Treatment Disparities.
    Cureus. 2025;17:e88967.
    

    >> Share

    
    
28. FERNANDES S, Mashharawi N, Bhutta AE, Varghese RM, et al
    Comparison of Self-Collected Versus Clinician-Collected Human Papillomavirus (HPV) Sampling for Cervical Cancer Screening: A Pilot Study in the United Arab Emirates.
    Cureus. 2025;17:e89250.
    

    >> Share

    
    

    
    Discov Oncol

29. XI M, Wang X, Xu X, Zhang J, et al
    Predictive value of MHC-related genes in cervical cancer: implications for immunotherapy and prognostic nomogram development.
    Discov Oncol. 2025;16:1662.
    

    >> Share

    
    

    
    Epidemiol Health

30. BAE S, Kang YJ, Ahn J, Jang BH, et al
    Socioeconomic factors affecting breast and cervical cancer screening compliance in Asian National Cancer Centers Alliance countries: a systematic review.
    Epidemiol Health. 2025 Aug 28:e2025050. doi: 10.4178/epih.e2025050.
    

    >> Share

    
    

    
    Folia Med Cracov

31. BALAJEWICZ-NOWAK M, Kabzinska-Turek M, Kosiawa V
    Association between cervical intraepithelial neoplasia progression and cervicovaginal microbiota status - narrative review.
    Folia Med Cracov. 2024;64:15-21.
    

    >> Share

    
    

    
    Front Immunol

32. LI L, Bo Y, Xue D, Qin L, et al
    Ferroptosis-immune crosstalk in cervical cancer: mechanisms and therapeutic implications.
    Front Immunol. 2025;16:1657905.
    

    >> Share

    
    

    
    Front Oncol

33. NIU S, Zhang L, Wang L, Zhang X, et al
    Hybrid feature fusion in cervical cancer cytology: a novel dual-module approach framework for lesion detection and classification using radiomics, deep learning, and reproducibility.
    Front Oncol. 2025;15:1595980.
    

    >> Share

    
    

    
    Ginekol Pol

34. BIBER W, Fras M, Ciechacka M, Al-Jeabory M, et al
    Adaptation to cancer among Polish patients with cervical cancer in relation to illness acceptance, life satisfaction, and dispositional optimism.
    Ginekol Pol. 2025 Sep 5. doi: 10.5603/gpl.108039.
    

    >> Share

    
    

    
    Indian J Public Health

35. DAS S, Sahay MR, Singh AK, Roy P, et al
    Integrating Cervical Cancer Screening and Human Immunodeficiency Virus Care among Women Living with Human Immunodeficiency Virus: A Call for Action.
    Indian J Public Health. 2025;69.
    

    >> Share

    
    

    
    Int J Biol Macromol

36. LI N, Zhou S, Zhang Y, Li R, et al
    Immunochromatographic assay for rapid detection of SIGLEC15 to evaluate its therapeutic potential in cervical cancer.
    Int J Biol Macromol. 2025;324.
    

    >> Share

    
    

    
    Int J Gynaecol Obstet

37. YANAIHARA N, Tse KY, Lee SJ, Yoo JG, et al
    Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:166-188.
    

    >> Share

    
    
38. MCCLUGGAGE WG
    New histopathological and molecular findings in gynecological cancers.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70283.
    

    >> Share

    
    
39. BHATLA N, Aoki D, Sharma DN, Sankaranarayanan R, et al
    Cancer of the cervix uteri: 2025 update.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:87-108.
    

    >> Share

    
    
40. RUZINDANA K, Anorlu RI
    Global disparities in gynecologic cancer outcomes: A call for action.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:210-220.
    

    >> Share

    
    
41. PAIBOONBORIRAK C, Abu-Rustum NR, Wilailak S
    Artificial intelligence in the diagnosis and management of gynecologic cancer.
    Int J Gynaecol Obstet. 2025 Apr 25. doi: 10.1002/ijgo.70094.
    

    >> Share

    
    
42. WILAILAK S, Kengsakul M, Kehoe S
    Strategic approaches for global cervical cancer elimination: An update review and call for national action.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:120-128.
    

    >> Share

    
    

    
    Int J Gynecol Cancer

43. GAO X, Kong Y, Ning Y, Cui Z, et al
    Clinical characteristics and prognosis of rhabdomyosarcoma in the female reproductive system: a population-based analysis using SEER data.
    Int J Gynecol Cancer. 2025;35:101989.
    

    >> Share

    
    
44. BAEK JY, Park W, Cho WK, Kim HS, et al
    Surgery plus post-operative radiotherapy versus definitive chemoradiotherapy in locally advanced endocervical adenocarcinoma.
    Int J Gynecol Cancer. 2025;35:102013.
    

    >> Share

    
    
45. KOBAYASHI M, Nakagawa S, Masuda T, Kakuda M, et al
    Clinical and pathological characteristics and outcomes of small cell neuroendocrine carcinoma of the uterine cervix.
    Int J Gynecol Cancer. 2025;35:102011.
    

    >> Share

    
    

    
    Int J Public Health

46. OGUNSOLA O, Gaydos LM, Ajayi O, Dieci M, et al
    The CHESS Protocol: A Mixed-Methods Evaluation of an HPV Screening Intervention for Women Living With HIV in Nigeria.
    Int J Public Health. 2025;70:1608716.
    

    >> Share

    
    

    
    Integr Cancer Ther

47. VAN WIETMARSCHEN HA, Area-Gomez E, Picard M, Goodheart MJ, et al
    Metabolic Effects of Healing Touch During Cervical Cancer Treatment: An Exploratory Analysis.
    Integr Cancer Ther. 2025;24:15347354251367793.
    

    >> Share

    
    

    
    Iran J Basic Med Sci

48. ALIKHANZADEH M, Imanparast A, Einafshar E, Gholamhosseinian H, et al
    Evaluation of Cherenkov-induced photodynamic therapy of biohybrid photosensitive graphene oxide nanoplatform in cervical cancer cells.
    Iran J Basic Med Sci. 2025;28:1392-1405.
    

    >> Share

    
    

    
    J Cancer Res Clin Oncol

49. QUAYSON H, Bonney JHK, Sam D, Nuer-Allornuvor GF, et al
    Expression patterns of plasma microRNAs in patients with cervical cancer from two teaching hospitals in Ghana.
    J Cancer Res Clin Oncol. 2025;151:242.
    

    >> Share

    
    

    
    J Cancer Res Ther

50. ZHOU L, Bai Y, Diao P, Zeng S, et al
    Comparison of postoperative adjuvant therapy for early-stage cervical cancer: A surveillance, epidemiology, and end results analysis.
    J Cancer Res Ther. 2025;21:834-841.
    

    >> Share

    
    

    
    J Gynecol Oncol

51. WANG Y, Lu Q, Na J, Wang X, et al
    Safety and efficacy of radical hysterectomy based on embryo development-originated in the treatment of early cervical cancer: a single-arm meta-analysis.
    J Gynecol Oncol. 2025 Aug 25. doi: 10.3802/jgo.2026.
    

    >> Share

    
    

    
    J Infect Public Health

52. UYAR NY, Bodur H, Erdem MO, Altinisik IAK, et al
    Concentrated urine as an alternative to cervical smear samples enabling easy screening of HPV in large populations.
    J Infect Public Health. 2025;18:102857.
    

    >> Share

    
    

    
    J Med Life

53. SAVELIEV GM, Varlas VN, Piron-Dumitrascu M, Suciu N, et al
    Cervical cancer screening in Europe and Romania: a review of policies, progress, and persistent disparities.
    J Med Life. 2025;18:604-607.
    

    >> Share

    
    

    
    J Multidiscip Healthc

54. TOFFAHA K, Simsekler MCE, Sleptchenko A, Kortt MA, et al
    A Machine Learning and Bayesian Belief Network Approach to Predicting Cervical Cancer Risk: Implications for Risk Management.
    J Multidiscip Healthc. 2025;18:5199-5211.
    

    >> Share

    
    

    
    J Proteome Res

55. NI M, Wan D, Li M, Wu J, et al
    Deficiency of the UBE2C/F264 Axis Underlies Intrinsic Radioresistance in Cervical Carcinoma.
    J Proteome Res. 2025;24:4665-4673.
    

    >> Share

    
    

    
    JNCI Cancer Spectr

56. KRIEGER N, Moallef S, Cowger TL, Chen JT, et al
    Political determinants of US states' screening-amenable cancer stage at diagnosis and premature cancer mortality.
    JNCI Cancer Spectr. 2025;9:pkaf073.
    

    >> Share

    
    

    
    Kaohsiung J Med Sci

57. WANG Y, Li C
    MYB Activates the Hedgehog Signaling Pathway to Repress Natural Killer Cytotoxicity in Cervical Cancer.
    Kaohsiung J Med Sci. 2025 Sep 1:e70084. doi: 10.1002/kjm2.70084.
    

    >> Share

    
    

    
    MethodsX

58. R A, Prasad S
    A blockchain-enabled healthcare system for cervical cancer risk prediction using enhanced metaheuristic optimised graph convolutional attention based GRU.
    MethodsX. 2025;15:103564.
    

    >> Share

    
    

    
    Pathol Res Pract

59. LAOHAWETWANIT T, Apornvirat S, Asaturova A, Li H, et al
    Evaluation of general-purpose large language models as diagnostic support tools in cervical cytology.
    Pathol Res Pract. 2025;274:156159.
    

    >> Share

    
    

    
    PLoS One

60. BULAMBA RM, Kyasanku E, Nalugoda F, Daama A, et al
    Assessing Knowledge, Uptake and Factors associated with cervical cancer screening among women in selected communities of Wakiso district in Uganda: A population-based study.
    PLoS One. 2025;20:e0317641.
    

    >> Share

    
    
61. DEN'O ZD, Paulos W, Markos D, Oche WO, et al
    Human papilloma virus vaccination uptake and associated factors among adolescent girls in Merab Abaya district, Gamo zone, Southern Ethiopia: Mixed methods.
    PLoS One. 2025;20:e0330760.
    

    >> Share

    
    

    
    Radiother Oncol

62. SERBAN M, Spampinato S, de Leeuw A, Fortin I, et al
    Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis.
    Radiother Oncol. 2025;210:110954.
    

    >> Share

    
    

    
    Reprod Sci

63. ZOU D, Wu X, Xin X, Xu T, et al
    Construction and Validation of a Novel Prognostic Model Based on Cervical Cancer-Related Genes.
    Reprod Sci. 2025 Sep 4. doi: 10.1007/s43032-025-01973.
    

    >> Share

    
    

    
    Rev Panam Salud Publica

64. BARCENA BARBEIRA P, Paolino M, Binder F, Almonte M, et al
    Implementation of second round of HPV-based screening for cervical cancer in programmatic contexts in Argentina.
    Rev Panam Salud Publica. 2025;49:e92.
    

    >> Share

    
    

    
    Rev Peru Med Exp Salud Publica

65. ROSAS-MENDOZA MA, Santos-Rosales YR, Chilipio-Chiclla MA
    Frequency and factors associated with the preference for self-testing for human papillomavirus detection.
    Rev Peru Med Exp Salud Publica. 2025;42:166-174.
    

    >> Share

    
    

    
    Saudi Med J

66. BANJER HJ, Tayeb HH, Alzahrani KJ, Alsufiani SM, et al
    Cervical cancer risk and high-risk HPV types distribution in Saudi Arabia: Trends from a national laboratory-based study.
    Saudi Med J. 2025;46:992-999.
    

    >> Share

    
    

    
    Sci Rep

67. ZHANG T, Ji T, Duan Z, Xue Y, et al
    Retraction Note: Long non-coding RNA MLLT4 antisense RNA 1 induces autophagy to inhibit tumorigenesis of cervical cancer through modulating the myosin-9/ATG14 axis.
    Sci Rep. 2025;15:32078.
    

    >> Share

    
    
68. MASAMBA MAKANANI C, Nyondo-Mipando AL, Jumbe V
    Barriers and strategies to enhance HPV vaccine uptake in adolescents living with HIV and their guardians in Lilongwe, Malawi.
    Sci Rep. 2025;15:32230.
    

    >> Share

    
    
69. LIU Y, Li R, Du H, Wu R, et al
    HPV negative conversion following Hiporfin PDT for HPV associated HSIL in the female lower reproductive tract.
    Sci Rep. 2025;15:31973.
    

    >> Share

    
    

    
    Support Care Cancer

70. NOGUEIRA CM, Reis BS, Meneses AFP, Mellado BH, et al
    Unveiling delays: understanding the diagnostic pathways of women with advanced cervical cancer.
    Support Care Cancer. 2025;33:826.
    

    >> Share

    
    

    
    Toxicol Appl Pharmacol

71. YANG G, Mo Y, Rong H, Guo B, et al
    Caulerpin suppresses tumor-associated angiogenesis and tumor growth via Hippo signaling in cervical cancer.
    Toxicol Appl Pharmacol. 2025;504:117541.
    

    >> Share

    
    

    
    Transl Oncol

72. JIA Y, Zhang F, Zou K, Zou L, et al
    A clinical study on the efficacy of concurrent chemoradiotherapy combined with targeted therapy and hyperthermia in patients with locally advanced cervical cancer.
    Transl Oncol. 2025;61:102516.
    

    >> Share

    
    

    
    Turk J Obstet Gynecol

73. GULER CEKIC S, Bulut M, Aldikactioglu Talmac M, Aydin E, et al
    Risk factors for parametrial invasion in early-stage cervical cancer: Toward less radical surgery.
    Turk J Obstet Gynecol. 2025;22:237-245.
    

    >> Share

    
    
74. YANAZUME S, Kitazono I, Togami S, Tanimoto A, et al
    Potential biomarkers for predicting the efficacy of a pembrolizumab-containing regimen in advanced cervical cancer: A real-world analysis.
    Turk J Obstet Gynecol. 2025;22:246-256.
    

    >> Share

    
    

    
    Women Health

75. PURDY NL, Katz ML, Reiter PL
    Women's acceptability of HPV self-collection in a healthcare setting following FDA approval in the United States.
    Women Health. 2025;65:606-617.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share